Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synergistic Effect of Estradiol and Testosterone in Postmenopausal Osteoporosis
ChiCTR-OPC-16010120Phase 4Recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alendronate, calcium carbonate and calcitriol in involutional osteoporosis and osteopenia (3 arms), sponsored by Liaocheng City People's Hospital. Primary endpoints: bone mineral density, gonadal hormone levels and 1 more. Started Dec 2016; status: recruiting.
02
Drugs
alendronatecalcium carbonatecalcitriol
03
Conditions
involutional osteoporosisosteopenia
Beyond the preview
Go deeper on ChiCTR-OPC-16010120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16010120.